Aurobindo Pharma, JK Lakshmi Cement and Dhampur Bio Organics to see some action today

05 Jun 2026 Evaluate

Aurobindo Pharma has received a final approval from the US Food & Drug Administration (USFDA) to manufacture and market Tofacitinib Tablets, 5 mg and 10 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xeljanz Tablets, 5 mg and 10 mg, of PF Prism C.V. The product will be manufactured at APL Healthcare Unit IV, a wholly owned subsidiary of the company and will be launched immediately.

JK Lakshmi Cement has received approval for investment of 26% in Equity Shares of Special Purpose Vehicles (SPVs) i.e. DynoSpark and Elevate Solar Energy for purchase of solar power under the applicable captive power route. The company has been continuously exploring the possibility of increasing the Sourcing of Renewable Power to reduce the cost of power at its various Plant locations.

Dhampur Bio Organics has signed a Joint Venture Agreement with Orgonew on June 04, 2026 for development, manufacture, marketing, distribution, and commercialisation of phyto bio-active based functional food products and other products meant for human consumption and/or usage, through a Joint Venture Company (JVC). Pursuant to the Joint Venture Agreement, the company will hold 74% and Orgonew will hold 26% of the equity share capital of the JVC.

CG Power and Industrial Solutions (CG) has commissioned its extra high-voltage (EHV) switchgear manufacturing facility, S3 Unit-II, in Pimpalgaon Garudeshwar, Nashik, Maharashtra. This is in addition to the S3 Unit-I manufacturing facility at Ambad, Nashik which manufactures EHV circuit breakers in the 33kV to 800kV. The new facility will manufacture EHV Circuit Breakers in the 33 kV to 245 kV range and expands CG's EHV circuit breaker manufacturing capacity by 80%.

Tata Technologies has launched of the 4th edition of its flagship engineering innovation hackathon, InnoVent-27. Building on its continued success, this year the initiative has been further strengthened and taken a notch higher in collaboration with Emerson’s Test & Measurement business and Amazon Web Services (AWS). InnoVent-27 offers engineering students across India an inspiring platform to tackle real-world industrial challenges by deploying advanced computing directly where the data is generated.

Jay Ambe Supermarkets has entered into a registered lease arrangement on June 3, 2026 for commercial premises situated at Bayad, District Arvalli, Gujarat, for the purpose of establishing a new supermarket under the brand name ‘City Square Mart’. The said leasing arrangement forms part of the company’s ongoing business expansion and retail growth strategy.

Karur Vysya Bank (KVB) has strengthened its presence in Tamil Nadu by opening a new branch in Villivakkam, Chennai. This marks the Bank’s 903rd branch nationwide. KVB remains committed to providing accessible, world-class digital tools and personalised service, and believes this growth will empower residents and businesses, drive job creation, and foster relationships built on trust and innovation. Strategically located to serve the residential and commercial neighbourhoods of Sidco Nagar, the new branch will enhance access to financial services for local businesses, professionals, and residents, supporting long-term regional development.

Aurobindo Pharma, JK Lakshmi Cement and Dhampur Bio Organics to see some action today

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.